Kog is going deeper to squeeze more inference out of GPUs

Kog is using software optimization to target up to “30x faster” LLM inference on standard datacenter GPUs, which it says achieved 3,000 tokens/second in a demo using Laneformer 2B. The company is starting with larger-model acceleration and expects a first major model at 10x speed in September to prove traction ahead of a Series A. While still early and limited by time-intensive per-GPU engineering, investor and partner interest appears supportive as inference latency/cost become a key bottleneck.

Analysis

This is less a hardware threat than a margin-efficiency story. If software can materially improve decoding on installed GPUs, the first-order beneficiary is the GPU incumbent ecosystem: NVDA and, to a lesser extent, AMD, because it widens the addressable inference workload without forcing customers into a new silicon standard. The second-order effect is on buying behavior: enterprises may be more willing to deploy AI broadly if they can extract more throughput from sunk capex, which should support utilization at hyperscalers even if it modestly delays replacement cycles.

The true pressure point is on dedicated inference ASIC narratives and any vendor pitching raw speed as the sole moat. If a small team can show credible gains on large models, CBRS-style hardware differentiation gets pushed from a "must-buy" to a "nice-to-have," especially over the next 1-3 months as the market waits for proof on real LLMs, not toy demos. That said, the near-term risk cuts both ways: if efficiency extends GPU life, the immediate revenue benefit to NVDA/AMD could lag while customers test software first.

The key catalyst is the September large-model proof point. If Kog clears that bar with production-relevant workloads, the market will likely re-rate inference as a software optimization race, not a hardware replacement race; if it misses, this becomes another demo-driven AI microcap story with no durable read-through. Consensus may be underestimating how much faster inference lowers cost per token and expands demand, but overestimating how quickly that translates into incremental GPU shipments. The setup is more "watch list" than urgent trade unless the stock market starts pricing CBRS as an unavoidable share gainer.

Key Decisions for Investors

• Stay long NVDA / AMD versus any inference-ASIC basket only on confirmation of real large-model benchmarks in September; the trade is for 1-3 month follow-through, not the headline.
• Use any post-IPO strength in CBRS to fade the 'GPU replacement' narrative: initiate a small short or buy puts only if the market starts capitalizing software demos as durable share gains, since the proof is still incomplete.
• For AI infrastructure exposure, prefer NVDA over smaller accelerator names until there is evidence that software optimization meaningfully shifts enterprise purchasing away from CUDA/installed GPU fleets.
• Set a watch item on NVDA/AMD management commentary around inference utilization and cloud capex in the next earnings cycle; a flat capex outlook despite better efficiency would falsify the immediate upside case.